180 related articles for article (PubMed ID: 35589016)
21. Alisol B Alleviates Hepatocyte Lipid Accumulation and Lipotoxicity via Regulating RARα-PPARγ-CD36 Cascade and Attenuates Non-Alcoholic Steatohepatitis in Mice.
Zhao Z; Deng ZT; Huang S; Ning M; Feng Y; Shen Y; Zhao QS; Leng Y
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745142
[TBL] [Abstract][Full Text] [Related]
22. Cluster of Differentiation 36 Deficiency Aggravates Macrophage Infiltration and Hepatic Inflammation by Upregulating Monocyte Chemotactic Protein-1 Expression of Hepatocytes Through Histone Deacetylase 2-Dependent Pathway.
Zhong S; Zhao L; Wang Y; Zhang C; Liu J; Wang P; Zhou W; Yang P; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
Antioxid Redox Signal; 2017 Aug; 27(4):201-214. PubMed ID: 27967209
[TBL] [Abstract][Full Text] [Related]
23. B-cell lymphoma 6 alleviates nonalcoholic fatty liver disease in mice through suppression of fatty acid transporter CD36.
Zhang H; Li Y; Zhang C; Huang K; Zhao J; Le S; Jiang L; Liu H; Yang P; Xiao X; Yu J; Wu J; Ye P; Xia J
Cell Death Dis; 2022 Apr; 13(4):359. PubMed ID: 35436984
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.
Wright MC; Wang XJ; Pimenta M; Ribeiro V; Paine AJ; Lechner MC
Mol Pharmacol; 1996 Oct; 50(4):856-63. PubMed ID: 8863830
[TBL] [Abstract][Full Text] [Related]
25. High-fat diet-induced increases in glucocorticoids contribute to the development of non-alcoholic fatty liver disease in mice.
Tsai SF; Hung HC; Shih MM; Chang FC; Chung BC; Wang CY; Lin YL; Kuo YM
FASEB J; 2022 Jan; 36(1):e22130. PubMed ID: 34959259
[TBL] [Abstract][Full Text] [Related]
26. BDE-47 induces metabolic dysfunction-associated steatotic liver disease (MASLD) through CD36-mediated increased fatty acid uptake and PPARα-induced abnormal fatty acid oxidation in BALB/c mice.
Xia B; Yu R; Liu J; Liu D; Li S; Yang L; Liu N; Liang B; Zeng J; Wei J; Lin G
Toxicol Lett; 2024 Jan; 391():100-110. PubMed ID: 38040069
[TBL] [Abstract][Full Text] [Related]
27. ATF4-mediated CD36 upregulation contributes to palmitate-induced lipotoxicity in hepatocytes.
Griffiths A; Wang J; Song Q; Lee SM; Cordoba-Chacon J; Song Z
Am J Physiol Gastrointest Liver Physiol; 2023 May; 324(5):G341-G353. PubMed ID: 36852918
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B Virus X Protein Induces Hepatic Steatosis by Enhancing the Expression of Liver Fatty Acid Binding Protein.
Wu YL; Peng XE; Zhu YB; Yan XL; Chen WN; Lin X
J Virol; 2016 Feb; 90(4):1729-40. PubMed ID: 26637457
[TBL] [Abstract][Full Text] [Related]
29. Transcription factor SOX2 contributes to nonalcoholic fatty liver disease development by regulating the expression of the fatty acid transporter CD36.
Shen C; Chen JH; Oh HR; Park JH
FEBS Lett; 2021 Oct; 595(19):2493-2503. PubMed ID: 34536973
[TBL] [Abstract][Full Text] [Related]
30. CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing.
Zeng H; Qin H; Liao M; Zheng E; Luo X; Xiao A; Li Y; Chen L; Wei L; Zhao L; Ruan XZ; Yang P; Chen Y
Mol Metab; 2022 Mar; 57():101428. PubMed ID: 34974159
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of glucocorticoid-induced alteration of vimentin by a glucocorticoid receptor antagonist RU486 in the organ-cultured rat lens.
Xie GL; Yan H; Lu ZF
Mol Vis; 2011 Jan; 17():32-40. PubMed ID: 21245955
[TBL] [Abstract][Full Text] [Related]
32. Dexamethasone inhibits pancreatic tumor growth in preclinical models: Involvement of activating glucocorticoid receptor.
Yao Y; Yao QY; Xue JS; Tian XY; An QM; Cui LX; Xu C; Su H; Yang L; Feng YY; Hao CY; Zhou TY
Toxicol Appl Pharmacol; 2020 Aug; 401():115118. PubMed ID: 32619553
[TBL] [Abstract][Full Text] [Related]
33. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
[No Abstract] [Full Text] [Related]
34. Glucocorticoids/glucocorticoid receptors effect on dopaminergic neurotransmitters in ADHD rats.
Chen Y; Zheng X; Xie L; Huang L; Ke Z; Zheng J; Lu H; Hu J
Brain Res Bull; 2017 May; 131():214-220. PubMed ID: 28458039
[TBL] [Abstract][Full Text] [Related]
35. The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells.
Pariante CM; Pearce BD; Pisell TL; Su C; Miller AH
J Endocrinol; 2001 May; 169(2):309-20. PubMed ID: 11312148
[TBL] [Abstract][Full Text] [Related]
36. Secretory Galectin-3 promotes hepatic steatosis via regulation of the PPARγ/CD36 signaling pathway.
Yu H; Yang F; Zhong W; Jiang X; Zhang F; Ji X; Xue M; Qiu Y; Yu J; Hu X; Chen J; Bao Z
Cell Signal; 2021 Aug; 84():110043. PubMed ID: 33991615
[TBL] [Abstract][Full Text] [Related]
37. Effect of Omega-3 Rich High-Fat Diet on Markers of Tissue Lipid Metabolism in Glucocorticoid-Treated Mice.
Son W; Brown K; Persinger A; Pryke A; Lin J; Powell Z; Wallace N; van der Merwe M; Puppa M
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511252
[TBL] [Abstract][Full Text] [Related]
38. Interferon-alpha inhibits glucocorticoid receptor-mediated gene transcription via STAT5 activation in mouse HT22 cells.
Hu F; Pace TW; Miller AH
Brain Behav Immun; 2009 May; 23(4):455-63. PubMed ID: 19167480
[TBL] [Abstract][Full Text] [Related]
39. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
[TBL] [Abstract][Full Text] [Related]
40. Dexamethasone-induced hepatomegaly and steatosis in larval zebrafish.
Yin G; Cao L; Du J; Jia R; Kitazawa T; Kubota A; Teraoka H
J Toxicol Sci; 2017; 42(4):455-459. PubMed ID: 28717104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
